Beyond Meat's operating performance and corporate strategy have come into focus, which is bad news for investors.
Hørsholm, Denmark, 13 November 2025 - ExpreS2ion Biotech Holding AB ("ExpreS2ion") today announces its first nine months and third quarter 2025 results. The report is available as an attachment and on ...
Updated clinical development strategy based on positive data In the third quarter of 2025, Mendus shaped up its clinical development plans for the lead program vididencel in myeloid malignancies.The u ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback